Stemrx Bioscience Solutions Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 17-07-2024
- Paid Up Capital ₹ 0.13 M
as on 17-07-2024
- Company Age 10 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 M
as on 17-07-2024
- Revenue 121.09%
(FY 2023)
- Profit 72.27%
(FY 2023)
- Ebitda 35.21%
(FY 2023)
- Net Worth 26.97%
(FY 2023)
- Total Assets -3.51%
(FY 2023)
About Stemrx Bioscience Solutions
The Company is engaged in the Life Science Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.13 M.
The company currently has active open charges totaling ₹2.00 M.
Neetin Desai, Pradeep Mahajan, Siddhant Mahajan, and One other member serve as directors at the Company.
- CIN/LLPIN
U93030MH2014PTC253238
- Company No.
253238
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Feb 2014
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Navi Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Stemrx Bioscience Solutions Private Limited offer?
Stemrx Bioscience Solutions Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Fitness Supplements, Ayurvedic,Herbal Products & Medicine, Herbal Capsules, Ayurvedic Medicine, Medical Surgery & Treatment Centres, Medical Facilities, Nutritional Supplements, Dietary Supplements, Vitamin Tablets & Capsules.
Who are the key members and board of directors at Stemrx Bioscience Solutions?
Board Members(4)
Financial Performance and Corporate Structure Insights of Stemrx Bioscience Solutions.
Stemrx Bioscience Solutions Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 121.09% increase. The company also saw a substantial improvement in profitability, with a 72.27% increase in profit. The company's net worth Soared by an impressive increase of 26.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stemrx Bioscience Solutions?
In 2022, Stemrx Bioscience Solutions had a promoter holding of 80.00% and a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Age-Management Medicine And Research India Private Limited
Active
16 years 7 months Pradeep Mahajan and Vipula Mahajan are mutual person
Venkateshwara Heights Limited Liability Partnership
Active 12 years 2 months Pradeep Mahajan and Vipula Mahajan are mutual person
Kiranmaye Institute Of Medical Sciences Private Limited
Active 14 years 11 months Pradeep Mahajan is a mutual person
Velvet Medi Spa Private Limited
Active 13 years 8 months Pradeep Mahajan and Vipula Mahajan are mutual person
Medi-Check Health Services Private Limited
Active 12 years 3 months Pradeep Mahajan, Siddhant Mahajan and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Idbi Bank Limited Creation Date: 26 Aug 2015 | ₹2.00 M | Open |
How Many Employees Work at Stemrx Bioscience Solutions?
Stemrx Bioscience Solutions has a workforce of 7 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Jun 02, 2022, Stemrx Bioscience Solutions has raised a total of ₹ 2.46 Cr, with the most recent deal valued at ₹ 4.5 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
